Murepavadin antimicrobial activity against and resistance development in cystic fibrosis <i>Pseudomonas aeruginosa</i> isolates

Abstract

Murepavadin characteristics, such as its specific activity against P. aeruginosa, its unique mechanism of action and its strong antimicrobial activity, encourage the further clinical evaluation of this drug.